Posted by Michael Wonder on 29 Jan 2026
Cipher Pharmaceuticals announces Health Canada's acceptance for review of new drug submission for Natroba (spinosad)
28 January 2026 - Cipher Pharmaceuticals today announced that Health Canada has accepted for review Cipher's new drug submission for Natroba (spinosad) for the treatment of head lice and scabies.
Natroba (spinosad) is widely recognised as one of the most effective treatments for the two parasitic indications of head lice and scabies in the US.
